Prostate cancer: Intriguing data on inflammation and prostate cancer

Nature Reviews Urology

Volumn 11, Issue 7, 2014, Pages 369-370

  Vignozzi, Linda ^a   Maggi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; FINASTERIDE; INTERLEUKIN 6; INTERLEUKIN 8; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADAPTIVE IMMUNITY; CANCER PREVENTION; CANCER RISK; CANCER SURGERY; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; CLINICAL TRIAL (TOPIC); DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FOLLOW UP; GENE; GENE FREQUENCY; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; IL1RN GENE; INFLAMMATION; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; MSR1 GENE; MULTICENTER STUDY (TOPIC); NOTE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; PROSTATECTOMY; RNASEL GENE; STROMA CELL; TLR GENE; BIOPSY; BLOOD; CANCER GRADING; COMPLICATION; EVIDENCE BASED MEDICINE; MALE; PREDICTIVE VALUE; PROSTATIC NEOPLASMS; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

BIOPSY; EVIDENCE-BASED MEDICINE; HUMANS; INFLAMMATION; MALE; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84904059490     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2014.143     Document Type: Note

References (10)

1. Bostwick, D. G. et al. Human prostate cancer risk factors. Cancer 101 (Suppl.), 2371-2490 (2004).
2. De Marzo, A. M. et al. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7, 256-269 (2007).
3. Corona, G. et al. Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int. J. Endocrinol. 2014, 329456 (2014).
4. Vignozzi, L. et al. Benign prostatic hyperplasia: a new metabolic disease? J. Endocrinol. Invest. 37, 313-322 (2014).
5. Gurel, B. et al. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol. Biomarkers Prev. 23, 847-856 (2014).
6. Irani, J. et al. High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist Multi Center Study Group. Urology 54, 467-472 (1999).
7. Davidsson, S. et al. Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer. Cancer Epidemiol. Biomarkers Prev. 20, 2280-2287 (2011).
8. Yli-Hemminki, T. H. et al. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial. BJU Int. 112, 735-741 (2013).
9. Moreira, D. M. et al. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study. Cancer 120, 190-196 (2014).
10. Grimes, D. A. & Schulz, K. F. False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet. Gynecol. 120, 920-927 (2012).